source
- Dimension raises $800 million for third fund to boost AI-driven biotech venturesDimension, a venture capital firm focused on the intersection of technology and biotech, announced the closing of its largest fund to date, raising $800 million for its third fund, called Dimension…
- A-Alpha Bio launches AI antibody data consortium with GSK, Boltz and partnersA-Alpha Bio, a spin‑out founded by David Baker, announced the creation of a new consortium focused on sharing antibody design data. The group aims to address a shortage of high‑quality data that b…